TNF and colorectal carcinoma: Again, TNF/birinapant treatment was superior to TNF/ASTX660 in terms of cell death induction, essentially confirming the higher efficacy of birinapant to boost death receptor‐mediated killing in CRC cells (Fig. 2B).